To study the problems faced by innover from conception idea to filling patent in Indian pharmaceutical industry
-
Biogen Inc (BIIB) May Soon Trump Pfizer In Global CNS Drug Sales – Courtesy(bidnessetc.com)
Pharma Live, , Intellectual Property Rights, 0
Pfizer Inc. (NYSE:PFE), presently the world’s largest seller of central nervous system (CNS) drugs, may have its future lead...
-
Priority setting for orphan drugs: An international comparison
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0168851010002691-mainDownload
-
Brand owners file packaging patents – Courtesy (Packaging Digest)
Pharma Live, , Intellectual Property Rights, 0
Wm. Bolthouse Farms, Inc., Bakersfield, CA, inventive container permits point-of-use mixing of separate, compartmentalized ingredients without rupturing the main...
-
Comparing first level patent data with value-added patent information: A case study in the pharmaceutical field q
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0172219008000823-mainDownload
-
Channel strategy and orphan drugs – Courtesy (PMLiVe)
Pharma Live, , Intellectual Property Rights, 0
Channel strategy and orphan drugsA channel strategy is a plan for guiding decisions about a product’s distribution channel, ie...
-
An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0048733312002582-mainDownload
-
The Trans-Pacific Partnership And The Costs of Drug Patent Monopolies – Courtesy(OurFuture.org)
Pharma Live, , Intellectual Property Rights, 0
The debate over the Trans-Pacific Partnership (TPP) has taken center stage in policy circles in recent weeks. Its proponents...
-
Drug patents are Bad for your health: the cost of mismarketing – By Dean Baker
Pharma Live, , Intellectual Property Rights, 0
The rationale for granting patents for new drugs is to give companies incentives to research new and better drugs....
![](https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)